{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:21:16Z","timestamp":1772778076399,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22K07606"],"award-info":[{"award-number":["22K07606"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22J15573"],"award-info":[{"award-number":["22J15573"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["22K11891"],"award-info":[{"award-number":["22K11891"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["23H02843"],"award-info":[{"award-number":["23H02843"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["20K07931"],"award-info":[{"award-number":["20K07931"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJFR215H"],"award-info":[{"award-number":["JPMJFR215H"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s12035-024-04263-9","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T06:02:28Z","timestamp":1717394548000},"page":"109-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ido2 Deficiency Exacerbates Motor Impairment and Reduces Aryl Hydrocarbon Receptor Activity through Decreased Kynurenine in a Chronic Demyelinating Mouse Model"],"prefix":"10.1007","volume":"62","author":[{"given":"Kazuo","family":"Kunisawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koyo","family":"Yoshidomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuko","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwako","family":"Fujigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolati","family":"Wulaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aika","family":"Kosuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moeka","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"issue":"6","key":"4263_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1002\/glia.23134","volume":"65","author":"T Shimizu","year":"2017","unstructured":"Shimizu T, Wisessmith W, Li J, Abe M, Sakimura K, Chetsawang B, Sahara Y, Tohyama K et al (2017) The balance between cathepsin C and cystatin F controls remyelination in the brain of Plp1-overexpressing mouse, a chronic demyelinating disease model. Glia 65(6):917\u2013930. https:\/\/doi.org\/10.1002\/glia.23134","journal-title":"Glia"},{"issue":"3","key":"4263_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/ana.21640","volume":"65","author":"HL Weiner","year":"2009","unstructured":"Weiner HL (2009) The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann Neurol 65(3):239\u2013248. https:\/\/doi.org\/10.1002\/ana.21640","journal-title":"Ann Neurol"},{"key":"4263_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","volume":"7","author":"MD Lovelace","year":"2016","unstructured":"Lovelace MD, Varney B, Sundaram G, Franco NF, Ng ML, Pai S, Lim CK, Guillemin GJ et al (2016) Current Evidence for a Role of the Kynurenine Pathway of Tryptophan Metabolism in Multiple Sclerosis. Front Immunol 7:246. https:\/\/doi.org\/10.3389\/fimmu.2016.00246","journal-title":"Front Immunol"},{"issue":"Pt B","key":"4263_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","volume":"112","author":"MD Lovelace","year":"2017","unstructured":"Lovelace MD, Varney B, Sundaram G, Lennon MJ, Lim CK, Jacobs K, Guillemin GJ, Brew BJ (2017) Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases. Neuropharmacology 112(Pt B):373\u2013388. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.024","journal-title":"Neuropharmacology"},{"issue":"10","key":"4263_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nm934","volume":"9","author":"C Uyttenhove","year":"2003","unstructured":"Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van den Eynde BJ (2003) Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9(10):1269\u20131274. https:\/\/doi.org\/10.1038\/nm934","journal-title":"Nat Med"},{"issue":"11","key":"4263_CR6","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","volume":"176","author":"F Fallarino","year":"2006","unstructured":"Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, Orabona C, Bianchi R et al (2006) The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176(11):6752\u20136761. https:\/\/doi.org\/10.4049\/jimmunol.176.11.6752","journal-title":"J Immunol"},{"issue":"12","key":"4263_CR7","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.4049\/jimmunol.0804328","volume":"182","author":"GN Scott","year":"2009","unstructured":"Scott GN, DuHadaway J, Pigott E, Ridge N, Prendergast GC, Muller AJ, Mandik-Nayak L (2009) The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity. J Immunol 182(12):7509\u20137517. https:\/\/doi.org\/10.4049\/jimmunol.0804328","journal-title":"J Immunol"},{"issue":"3","key":"4263_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/intimm\/dxz003","volume":"31","author":"R Metz","year":"2019","unstructured":"Metz R, Smith C, DuHadaway JB, Chandler P, Baban B, Merlo LMF, Pigott E, Keough MP et al (2019) IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int Immunol 31(3):181\u2013182. https:\/\/doi.org\/10.1093\/intimm\/dxz003","journal-title":"Int Immunol"},{"issue":"15","key":"4263_CR9","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","volume":"67","author":"R Metz","year":"2007","unstructured":"Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC (2007) Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res 67(15):7082\u20137087. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-1872","journal-title":"Cancer Res"},{"issue":"5","key":"4263_CR10","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.4049\/jimmunol.1303012","volume":"192","author":"LMF Merlo","year":"2014","unstructured":"Merlo LMF, Pigott E, DuHadaway JB, Grabler S, Metz R, Prendergast GC, Mandik-Nayak L (2014) IDO2 is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis. J Immunol 192(5):2082\u20132090. https:\/\/doi.org\/10.4049\/jimmunol.1303012","journal-title":"J Immunol"},{"issue":"11","key":"4263_CR11","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.4049\/jimmunol.1600141","volume":"196","author":"LM Merlo","year":"2016","unstructured":"Merlo LM, DuHadaway JB, Grabler S, Prendergast GC, Muller AJ, Mandik-Nayak L (2016) IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism. J Immunol 196(11):4487\u20134497. https:\/\/doi.org\/10.4049\/jimmunol.1600141","journal-title":"J Immunol"},{"issue":"1","key":"4263_CR12","doi-asserted-by":"publisher","first-page":"15917","DOI":"10.1038\/s41598-018-34166-4","volume":"8","author":"Y Yamamoto","year":"2018","unstructured":"Yamamoto Y, Yamasuge W, Imai S, Kunisawa K, Hoshi M, Fujigaki H, Mouri A, Nabeshima T, Saito K (2018) Lipopolysaccharide shock reveals the immune function of indoleamine 2,3-dioxygenase 2 through the regulation of IL-6\/stat3 signalling. Sci Rep 8(1):15917. https:\/\/doi.org\/10.1038\/s41598-018-34166-4","journal-title":"Sci Rep"},{"key":"4263_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jns.2017.03.048","volume":"377","author":"C Agliardi","year":"2017","unstructured":"Agliardi C, Guerini FR, Zanzottera M, Rovaris M, Caputo D, Clerici M (2017) Indoleamine-2,3-dioxygenase(IDO)2 polymorphisms are not associated with multiple sclerosis in Italians. J Neurol Sci 377:31\u201334. https:\/\/doi.org\/10.1016\/j.jns.2017.03.048","journal-title":"J Neurol Sci"},{"issue":"5","key":"4263_CR14","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.4049\/jimmunol.1601139","volume":"198","author":"L Negrotto","year":"2017","unstructured":"Negrotto L, Correale J (2017) Amino Acid Catabolism in Multiple Sclerosis Affects Immune Homeostasis. J Immunol 198(5):1900\u20131909. https:\/\/doi.org\/10.4049\/jimmunol.1601139","journal-title":"J Immunol"},{"key":"4263_CR15","doi-asserted-by":"publisher","first-page":"100116","DOI":"10.1016\/j.bbih.2020.100116","volume":"7","author":"LA Wetzel","year":"2020","unstructured":"Wetzel LA, Hurtado M, MacDowell Kaswan ZA, McCusker RH, Steelman AJ (2020) Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG(35\u201355)-induced experimental autoimmune encephalomyelitis. Brain Behav Immun Health 7:100116. https:\/\/doi.org\/10.1016\/j.bbih.2020.100116","journal-title":"Brain Behav Immun Health"},{"issue":"2","key":"4263_CR16","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0896-6273(94)90358-1","volume":"13","author":"T Kagawa","year":"1994","unstructured":"Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J et al (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13(2):427\u2013442. https:\/\/doi.org\/10.1016\/0896-6273(94)90358-1","journal-title":"Neuron"},{"key":"4263_CR17","doi-asserted-by":"publisher","first-page":"113191","DOI":"10.1016\/j.bbr.2021.113191","volume":"405","author":"Y Mori","year":"2021","unstructured":"Mori Y, Mouri A, Kunisawa K, Hirakawa M, Kubota H, Kosuge A, Niijima M, Hasegawa M et al (2021) Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of alpha7 nicotinic acetylcholine receptors by kynurenic acid. Behav Brain Res 405:113191. https:\/\/doi.org\/10.1016\/j.bbr.2021.113191","journal-title":"Behav Brain Res"},{"issue":"2","key":"4263_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ajpath.2012.10.018","volume":"182","author":"OM Dorchies","year":"2013","unstructured":"Dorchies OM, Reutenauer-Patte J, Dahmane E, Ismail HM, Petermann O, Patthey- Vuadens O, Comyn SA, Gayi E et al (2013) The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy. Am J Pathol 182(2):485\u2013504. https:\/\/doi.org\/10.1016\/j.ajpath.2012.10.018","journal-title":"Am J Pathol"},{"issue":"6","key":"4263_CR19","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1111\/jnc.15222","volume":"157","author":"WJ Suento","year":"2021","unstructured":"Suento WJ, Kunisawa K, Wulaer B, Kosuge A, Iida T, Fujigaki S, Fujigaki H, Yamamoto Y et al (2021) Prefrontal cortex miR-874-3p prevents lipopolysaccharide-induced depression-like behavior through inhibition of indoleamine 2,3-dioxygenase 1 expression in mice. J Neurochem 157(6):1963\u20131978. https:\/\/doi.org\/10.1111\/jnc.15222","journal-title":"J Neurochem"},{"issue":"1","key":"4263_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13041-020-00698-y","volume":"13","author":"K Kunisawa","year":"2020","unstructured":"Kunisawa K, Hatanaka N, Shimizu T, Kobayashi K, Osanai Y, Mouri A, Shi Q, Bhat MA et al (2020) Focal loss of the paranodal domain protein Neurofascin155 in the internal capsule impairs cortically induced muscle activity in vivo. Mol Brain 13(1):159. https:\/\/doi.org\/10.1186\/s13041-020-00698-y","journal-title":"Mol Brain"},{"issue":"2","key":"4263_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1247\/csf.18009","volume":"43","author":"M Handa-Narumi","year":"2018","unstructured":"Handa-Narumi M, Yoshimura T, Konishi H, Fukata Y, Manabe Y, Tanaka K, Bao GM, Kiyama H et al (2018) Branched Sialylated N-glycans Are Accumulated in Brain Synaptosomes and Interact with Siglec-H. Cell Struct Funct 43(2):141\u2013152. https:\/\/doi.org\/10.1247\/csf.18009","journal-title":"Cell Struct Funct"},{"issue":"3","key":"4263_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jnc.14581","volume":"148","author":"WW Durose","year":"2019","unstructured":"Durose WW, Shimizu T, Li J, Abe M, Sakimura K, Chetsawang B, Tanaka KF, Suzumura A et al (2019) Cathepsin C modulates myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Neurochem 148(3):413\u2013425. https:\/\/doi.org\/10.1111\/jnc.14581","journal-title":"J Neurochem"},{"issue":"2","key":"4263_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11064-006-9183-y","volume":"32","author":"J Ma","year":"2007","unstructured":"Ma J, Tanaka KF, Yamada G, Ikenaka K (2007) Induced expression of cathepsins and cystatin C in a murine model of demyelination. Neurochem Res 32(2):311\u2013320. https:\/\/doi.org\/10.1007\/s11064-006-9183-y","journal-title":"Neurochem Res"},{"issue":"6","key":"4263_CR24","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/jnc.15190","volume":"157","author":"J Li","year":"2021","unstructured":"Li J, Durose WW, Ito J, Kakita A, Iguchi Y, Katsuno M, Kunisawa K, Shimizu T et al (2021) Exploring the factors underlying remyelination arrest by studying the post-transcriptional regulatory mechanisms of cystatin F gene. J Neurochem 157(6):2070\u20132090. https:\/\/doi.org\/10.1111\/jnc.15190","journal-title":"J Neurochem"},{"issue":"5","key":"4263_CR25","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jhep.2010.04.037","volume":"53","author":"M Kinoshita","year":"2010","unstructured":"Kinoshita M, Uchida T, Sato A, Nakashima M, Nakashima H, Shono S, Habu Y, Miyazaki H et al (2010) Characterization of two F4\/80-positive Kupffer cell subsets by their function and phenotype in mice. J Hepatol 53(5):903\u2013910. https:\/\/doi.org\/10.1016\/j.jhep.2010.04.037","journal-title":"J Hepatol"},{"issue":"6","key":"4263_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/intimm\/dxt011","volume":"25","author":"NT Nguyen","year":"2013","unstructured":"Nguyen NT, Hanieh H, Nakahama T, Kishimoto T (2013) The roles of aryl hydrocarbon receptor in immune responses. Int Immunol 25(6):335\u2013343. https:\/\/doi.org\/10.1093\/intimm\/dxt011","journal-title":"Int Immunol"},{"key":"4263_CR27","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fimmu.2014.00585","volume":"5","author":"GC Prendergast","year":"2014","unstructured":"Prendergast GC, Metz R, Muller AJ, Merlo LM, Mandik-Nayak L (2014) IDO2 in immunomodulation and autoimmune disease. Front Immunol 5:585. https:\/\/doi.org\/10.3389\/fimmu.2014.00585","journal-title":"Front Immunol"},{"key":"4263_CR28","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3389\/fimmu.2020.01861","volume":"11","author":"LMF Merlo","year":"2020","unstructured":"Merlo LMF, DuHadaway JB, Montgomery JD, Peng WD, Murray PJ, Prendergast GC, Caton AJ, Muller AJ et al (2020) Differential roles of IDO1 and IDO2 in T and B cell inflammatory immune responses. Front Immunol 11:1861. https:\/\/doi.org\/10.3389\/fimmu.2020.01861","journal-title":"Front Immunol"},{"key":"4263_CR29","doi-asserted-by":"publisher","unstructured":"Leuti A, Talamonti E, Gentile A, Tiberi M, Matteocci A, Fresegna D, Centonze D, Chiurchiu V (2021) Macrophage plasticity and polarization are altered in the experimental model of multiple sclerosis. Biomolecules 11(6):837. https:\/\/doi.org\/10.3390\/biom11060837","DOI":"10.3390\/biom11060837"},{"issue":"1","key":"4263_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13024-022-00577-1","volume":"17","author":"N Wang","year":"2022","unstructured":"Wang N, Wang M, Jeevaratnam S, Rosenberg C, Ikezu TC, Shue F, Doss SV, Alnobani A et al (2022) Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination. Mol Neurodegener 17(1):75. https:\/\/doi.org\/10.1186\/s13024-022-00577-1","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4263_CR31","doi-asserted-by":"publisher","first-page":"e2209990120","DOI":"10.1073\/pnas.2209990120","volume":"120","author":"LQ Zhou","year":"2023","unstructured":"Zhou LQ, Dong MH, Hu ZW, Tang Y, Chu YH, Chen M, Yang S, Chen Z et al (2023) Staged suppression of microglial autophagy facilitates regeneration in CNS demyelination by enhancing the production of linoleic acid. Proc Natl Acad Sci U S A 120(1):e2209990120. https:\/\/doi.org\/10.1073\/pnas.2209990120","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4263_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41593-020-00757-6","volume":"24","author":"SA Berghoff","year":"2021","unstructured":"Berghoff SA, Spieth L, Sun T, Hosang L, Schlaphoff L, Depp C, Duking T, Winchenbach J et al (2021) Microglia facilitate repair of demyelinated lesions via post-squalene sterol synthesis. Nat Neurosci 24(1):47\u201360. https:\/\/doi.org\/10.1038\/s41593-020-00757-6","journal-title":"Nat Neurosci"},{"issue":"10","key":"4263_CR33","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1212\/wnl.57.10.1885","volume":"57","author":"NL Sicotte","year":"2001","unstructured":"Sicotte NL, Voskuhl RR (2001) Onset of multiple sclerosis associated with anti-TNF therapy. Neurology 57(10):1885\u20131888. https:\/\/doi.org\/10.1212\/wnl.57.10.1885","journal-title":"Neurology"},{"issue":"7","key":"4263_CR34","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1056\/NEJM199108153250704","volume":"325","author":"MK Sharief","year":"1991","unstructured":"Sharief MK, Hentges R (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. N Engl J Med 325(7):467\u2013472. https:\/\/doi.org\/10.1056\/NEJM199108153250704","journal-title":"N Engl J Med"},{"issue":"6 Suppl 6","key":"4263_CR35","doi-asserted-by":"publisher","first-page":"S44","DOI":"10.1212\/wnl.45.6_suppl_6.s44","volume":"45","author":"KW Selmaj","year":"1995","unstructured":"Selmaj KW, Raine CS (1995) Experimental autoimmune encephalomyelitis: immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 45(6 Suppl 6):S44-49. https:\/\/doi.org\/10.1212\/wnl.45.6_suppl_6.s44","journal-title":"Neurology"},{"issue":"7","key":"4263_CR36","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/intimm\/dxt073","volume":"26","author":"R Metz","year":"2014","unstructured":"Metz R, Smith C, DuHadaway JB, Chandler P, Baban B, Merlo LM, Pigott E, Keough MP et al (2014) IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation. Int Immunol 26(7):357\u2013367. https:\/\/doi.org\/10.1093\/intimm\/dxt073","journal-title":"Int Immunol"},{"key":"4263_CR37","doi-asserted-by":"publisher","first-page":"15207","DOI":"10.1038\/ncomms15207","volume":"8","author":"Y Liu","year":"2017","unstructured":"Liu Y, Liang X, Yin X, Lv J, Tang K, Ma J, Ji T, Zhang H et al (2017) Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-gamma-induced immunologic dormancy of tumor-repopulating cells. Nat Commun 8:15207. https:\/\/doi.org\/10.1038\/ncomms15207","journal-title":"Nat Commun"},{"key":"4263_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psyneuen.2018.04.019","volume":"94","author":"AM Garrison","year":"2018","unstructured":"Garrison AM, Parrott JM, Tunon A, Delgado J, Redus L, O\u2019Connor JC (2018) Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation. Psychoneuroendocrinology 94:1\u201310. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.04.019","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"4263_CR39","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1084\/jem.20090560","volume":"206","author":"A Kimura","year":"2009","unstructured":"Kimura A, Naka T, Nakahama T, Chinen I, Masuda K, Nohara K, Fujii-Kuriyama Y, Kishimoto T (2009) Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 206(9):2027\u20132035. https:\/\/doi.org\/10.1084\/jem.20090560","journal-title":"J Exp Med"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04263-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04263-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04263-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T21:40:45Z","timestamp":1736372445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04263-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4263"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04263-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]},"assertion":[{"value":"16 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were performed according to the guidelines established by the Japanese Pharmacological Society and Institute for Experimental Animals at Fujita Health University. All protocols were approved by the Ethics Committee of Animal Experiments of the Institute for Experimental Animals at Fujita Health University (Permit Number: APU22059-MD1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"No applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}